FTC To Focus On In-House Challenge Of Illumina Deal
By Matthew Perlman ( May 20, 2021, 9:39 PM EDT) -- The Federal Trade Commission said Thursday enforcers plan to drop their bid for a court order to pause Illumina's planned $8 billion purchase of cancer testing company Grail and will instead focus on an administrative case challenging the tie-up....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.